Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-30

Clinical Trial Update: Brain Imaging of Quetiapine Response in Anxious Depression [Phase 4]

View source ↗

Summary

Phase 4 brain imaging study evaluating quetiapine response in anxious depression has completed, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Quetiapine (quetiapine)

Snippet

Sponsor: Indiana University School of Medicine | Conditions: Major Depression | Phase 4 | Status: COMPLETED | Results posted: 2016-09-30